Annual Operating Profit
-$4.79 M
+$3.89 M+44.83%
31 December 2023
Summary:
Sunshine Biopharma annual operaing income is currently -$4.79 million, with the most recent change of +$3.89 million (+44.83%) on 31 December 2023. During the last 3 years, it has fallen by -$4.21 million (-729.52%). SBFMW annual operating profit is now -36367.76% below its all-time high of -$13.12 thousand, reached on 31 July 2007.SBFMW Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$1.11 M
+$161.92 K+12.77%
30 September 2024
Summary:
Sunshine Biopharma quarterly operating income is currently -$1.11 million, with the most recent change of +$161.92 thousand (+12.77%) on 30 September 2024. Over the past year, it has dropped by -$326.88 thousand (-41.94%). SBFMW quarterly operating profit is now -173.16% below its all-time high of $1.51 million, reached on 30 September 2010.SBFMW Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$4.91 M
-$326.88 K-7.13%
30 September 2024
Summary:
Sunshine Biopharma TTM operating income is currently -$4.91 million, with the most recent change of -$326.88 thousand (-7.13%) on 30 September 2024. Over the past year, it has increased by +$3.72 million (+43.11%). SBFMW TTM operating profit is now -581.79% below its all-time high of $1.02 million, reached on 30 June 2011.SBFMW TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.8% | -41.9% | +43.1% |
| 3 y3 years | -729.5% | -122.9% | -96.2% |
| 5 y5 years | -310.2% | -446.0% | -811.8% |
SBFMW Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -729.5% | +44.8% | -295.6% | +78.0% | -105.7% | +48.7% |
| 5 y | 5 years | -729.5% | +44.8% | -2834.7% | +78.0% | -914.7% | +48.7% |
| alltime | all time | <-9999.0% | +44.8% | -173.2% | +78.0% | -581.8% | +48.7% |
Sunshine Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.11 M(-12.8%) | -$4.91 M(+7.1%) |
| June 2024 | - | -$1.27 M(-6.1%) | -$4.59 M(+6.5%) |
| Mar 2024 | - | -$1.35 M(+13.8%) | -$4.31 M(-10.0%) |
| Dec 2023 | -$4.79 M(-44.8%) | -$1.19 M(+52.3%) | -$4.79 M(-44.6%) |
| Sept 2023 | - | -$779.47 K(-21.2%) | -$8.63 M(-9.8%) |
| June 2023 | - | -$989.62 K(-45.9%) | -$9.57 M(+3.2%) |
| Mar 2023 | - | -$1.83 M(-63.7%) | -$9.28 M(+7.0%) |
| Dec 2022 | -$8.67 M(+255.5%) | -$5.04 M(+193.2%) | -$8.67 M(+121.5%) |
| Sept 2022 | - | -$1.72 M(+146.9%) | -$3.92 M(+45.3%) |
| June 2022 | - | -$695.80 K(-43.1%) | -$2.70 M(+12.9%) |
| Mar 2022 | - | -$1.22 M(+337.5%) | -$2.39 M(-2.1%) |
| Dec 2021 | -$2.44 M(+323.0%) | -$279.63 K(-43.7%) | -$2.44 M(-2.5%) |
| Sept 2021 | - | -$496.26 K(+27.7%) | -$2.50 M(+20.7%) |
| June 2021 | - | -$388.60 K(-69.5%) | -$2.07 M(+14.3%) |
| Mar 2021 | - | -$1.28 M(+271.6%) | -$1.81 M(+214.6%) |
| Dec 2020 | -$576.87 K(-10.1%) | -$343.32 K(+410.2%) | -$576.87 K(+19.2%) |
| Sept 2020 | - | -$67.29 K(-47.7%) | -$484.15 K(-21.8%) |
| June 2020 | - | -$128.57 K(+241.0%) | -$619.50 K(+11.2%) |
| Mar 2020 | - | -$37.70 K(-85.0%) | -$557.13 K(-13.0%) |
| Dec 2019 | -$641.64 K(-45.0%) | -$250.59 K(+23.7%) | -$640.23 K(+18.8%) |
| Sept 2019 | - | -$202.64 K(+206.1%) | -$538.77 K(-12.5%) |
| June 2019 | - | -$66.20 K(-45.2%) | -$615.89 K(-45.0%) |
| Mar 2019 | - | -$120.80 K(-19.0%) | -$1.12 M(-3.9%) |
| Dec 2018 | -$1.17 M(+36.1%) | -$149.13 K(-46.7%) | -$1.17 M(-1.1%) |
| Sept 2018 | - | -$279.75 K(-51.0%) | -$1.18 M(+16.4%) |
| June 2018 | - | -$570.95 K(+242.5%) | -$1.01 M(+10.8%) |
| Mar 2018 | - | -$166.70 K(+2.8%) | -$914.90 K(+6.7%) |
| Dec 2017 | -$857.19 K(-13.7%) | -$162.18 K(+42.5%) | -$857.19 K(-16.9%) |
| Sept 2017 | - | -$113.81 K(-75.9%) | -$1.03 M(-0.2%) |
| June 2017 | - | -$472.22 K(+333.3%) | -$1.03 M(+0.1%) |
| Mar 2017 | - | -$108.99 K(-67.6%) | -$1.03 M(+4.0%) |
| Dec 2016 | -$993.11 K | -$336.10 K(+189.7%) | -$993.11 K(+19.5%) |
| Sept 2016 | - | -$116.02 K(-75.4%) | -$831.25 K(+0.4%) |
| June 2016 | - | -$471.31 K(+576.4%) | -$828.29 K(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$69.68 K(-60.0%) | -$725.13 K(-7.1%) |
| Dec 2015 | -$780.28 K(-55.5%) | -$174.24 K(+54.1%) | -$780.28 K(-14.5%) |
| Sept 2015 | - | -$113.05 K(-69.3%) | -$912.34 K(-15.3%) |
| June 2015 | - | -$368.16 K(+194.9%) | -$1.08 M(-27.0%) |
| Mar 2015 | - | -$124.83 K(-59.2%) | -$1.47 M(-16.0%) |
| Dec 2014 | -$1.76 M(-9.3%) | -$306.30 K(+10.4%) | -$1.76 M(-17.8%) |
| Sept 2014 | - | -$277.43 K(-63.8%) | -$2.13 M(+4.9%) |
| June 2014 | - | -$765.51 K(+88.6%) | -$2.03 M(+43.1%) |
| Mar 2014 | - | -$405.87 K(-40.8%) | -$1.42 M(-26.7%) |
| Dec 2013 | -$1.94 M(+174.0%) | -$685.41 K(+285.7%) | -$1.94 M(+34.5%) |
| Sept 2013 | - | -$177.68 K(+16.4%) | -$1.44 M(-12.1%) |
| June 2013 | - | -$152.59 K(-83.5%) | -$1.64 M(+3.1%) |
| Mar 2013 | - | -$922.89 K(+390.2%) | -$1.59 M(+125.0%) |
| Dec 2012 | -$706.68 K(+27.1%) | -$188.26 K(-50.0%) | -$706.68 K(-20.6%) |
| Sept 2012 | - | -$376.41 K(+266.5%) | -$890.48 K(+41.2%) |
| June 2012 | - | -$102.69 K(+161.1%) | -$630.51 K(+15.8%) |
| Mar 2012 | - | -$39.33 K(-89.4%) | -$544.31 K(-1.8%) |
| Dec 2011 | -$556.20 K(+3.5%) | -$372.06 K(+219.5%) | -$554.20 K(-9.0%) |
| Sept 2011 | - | -$116.44 K(+606.1%) | -$609.09 K(-159.7%) |
| June 2011 | - | -$16.49 K(-66.5%) | $1.02 M(-284.7%) |
| Mar 2011 | - | -$49.22 K(-88.5%) | -$551.95 K(+2.7%) |
| Dec 2010 | -$537.38 K(+1960.6%) | -$426.95 K(-128.2%) | -$537.38 K(+386.6%) |
| Sept 2010 | - | $1.51 M(-195.2%) | -$110.44 K(-93.3%) |
| June 2010 | - | -$1.59 M(+4483.3%) | -$1.65 M(+2203.2%) |
| Mar 2010 | - | -$34.65 K(+8.3%) | -$71.84 K(+67.0%) |
| Oct 2009 | - | -$32.01 K(+516.5%) | -$43.02 K(+174.8%) |
| July 2009 | - | -$5191.00(+110.2%) | -$15.65 K(+6.4%) |
| Apr 2009 | - | -$2470.00(-26.3%) | -$14.70 K(-36.1%) |
| Jan 2009 | - | -$3353.00(-27.7%) | -$23.02 K(+5.0%) |
| Oct 2008 | - | -$4638.00(+9.3%) | -$21.93 K(-15.9%) |
| July 2008 | -$26.08 K(+98.7%) | -$4243.00(-60.6%) | -$26.08 K(+19.4%) |
| Apr 2008 | - | -$10.78 K(+376.0%) | -$21.84 K(+97.5%) |
| Jan 2008 | - | -$2265.00(-74.2%) | -$11.05 K(+25.8%) |
| Oct 2007 | - | -$8788.00 | -$8788.00 |
| July 2007 | -$13.12 K | - | - |
FAQ
- What is Sunshine Biopharma annual operaing income?
- What is the all time high annual operating profit for Sunshine Biopharma?
- What is Sunshine Biopharma annual operating profit year-on-year change?
- What is Sunshine Biopharma quarterly operating income?
- What is the all time high quarterly operating profit for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly operating profit year-on-year change?
- What is Sunshine Biopharma TTM operating income?
- What is the all time high TTM operating profit for Sunshine Biopharma?
- What is Sunshine Biopharma TTM operating profit year-on-year change?
What is Sunshine Biopharma annual operaing income?
The current annual operating profit of SBFMW is -$4.79 M
What is the all time high annual operating profit for Sunshine Biopharma?
Sunshine Biopharma all-time high annual operaing income is -$13.12 K
What is Sunshine Biopharma annual operating profit year-on-year change?
Over the past year, SBFMW annual operaing income has changed by +$3.89 M (+44.83%)
What is Sunshine Biopharma quarterly operating income?
The current quarterly operating profit of SBFMW is -$1.11 M
What is the all time high quarterly operating profit for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly operating income is $1.51 M
What is Sunshine Biopharma quarterly operating profit year-on-year change?
Over the past year, SBFMW quarterly operating income has changed by -$326.88 K (-41.94%)
What is Sunshine Biopharma TTM operating income?
The current TTM operating profit of SBFMW is -$4.91 M
What is the all time high TTM operating profit for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM operating income is $1.02 M
What is Sunshine Biopharma TTM operating profit year-on-year change?
Over the past year, SBFMW TTM operating income has changed by +$3.72 M (+43.11%)